共 21 条
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes and Th1 type polarization
被引:45
作者:
Ranki, Tuuli
[1
]
Joensuu, Timo
[2
]
Jaeger, Elke
[3
]
Karbach, Julia
[3
]
Wahle, Claudia
[3
]
Kairemo, Kalevi
[2
]
Alanko, Tuomo
[2
]
Partanen, Kaarina
[2
]
Turkki, Riku
[4
]
Linder, Nina
[4
]
Lundin, Johan
[4
]
Ristimaki, Ari
[5
,6
,7
]
Kankainen, Matti
[4
]
Hemminki, Akseli
[8
]
Backman, Charlotta
[1
]
Dienel, Kasper
[1
]
von Euler, Mikael
[1
]
Haavisto, Elina
[1
]
Hakonen, Tiina
[1
]
Juhila, Juuso
[1
]
Jaderberg, Magnus
[1
]
Priha, Petri
[1
]
Vassilev, Lotta
[1
]
Vuolanto, Antti
[1
]
Pesonen, Sari
[1
]
机构:
[1] Oncos Therapeut, Helsinki, Finland
[2] Docrates Canc Ctr, Helsinki, Finland
[3] Krankenhaus NW Frankfurt, Frankfurt, Germany
[4] Inst Mol Med Finland FIMM, Helsinki, Finland
[5] Univ Helsinki, Cent Hosp, Div Pathol, HUSLAB, Helsinki, Finland
[6] Univ Helsinki, Cent Hosp, Haartman Inst, Helsinki, Finland
[7] Univ Helsinki, Res Programs Unit, Helsinki, Finland
[8] Univ Helsinki, Haartman Inst, Canc Gene Therapy Grp, Helsinki, Finland
来源:
ONCOIMMUNOLOGY
|
2014年
/
3卷
/
10期
关键词:
Adenovirus;
antitumor immunity;
cytotoxic immunotherapy;
GM-CSF;
Th1;
polarization;
tumor infiltrating lymphocytes;
D O I:
10.4161/21624011.2014.958937
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Late stage cancer is often associated with reduced immune recognition and a highly immunosuppressive tumor microenvironment. The presence of tumor infiltrating lymphocytes (TILs) and specific gene-signatures prior to treatment are linked to good prognosis, while the opposite is true for extensive immunosuppression. The use of adenoviruses as cancer vaccines is a form of active immunotherapy to initialise a tumor-specific immune response that targets the patient's unique tumor antigen repertoire. We report a case of a 68-year-old male with asbestos-related malignant pleural mesothelioma who was treated in a Phase I study with a granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing oncolytic adenovirus, Ad5/3-D24-GMCSF (ONCOS-102). The treatment resulted in prominent infiltration of CD8(+) lymphocytes to tumor, marked induction of systemic antitumor CD8C T-cells and induction of Th1-type polarization in the tumor. These results indicate that ONCOS-102 treatment sensitizes tumors to other immunotherapies by inducing a T-cell positive phenotype to an initially T-cell negative tumor.
引用
收藏
页码:e958937 / 1
页数:4